About Index Trending news
Analyze
Pricing
Dermira, Inc.

Dermira, Inc.

Work at Dermira, Inc.? Add yourself to this profile

Dermira, Inc.

Dermira is a development-stage biotech company focused on developing andcommercializing innovative new therapies in dermatology.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$1,500,000
Venture capital (Series C)
$51,000,000
Canaan Partners, Aisling Capital, Rock Springs Capital, +5
Employees

Team size

10+
Locations
Xconomy

Dermira Commits $135M for Global Rights to Roche Eczema Drug

Health